1. 3) Hammerstingl C, Pötzsch B, Nickenig G: Resolution of giant left atrial appendage thrombus with rivaroxaban. Thromb Haemost 2013; 109: 583–584
2. 4) Sakatani A, Nishio M, Kume K, et al: Rivaroxaban for Fully Occlusive Inferior Vena Cava Filter Thrombus. Circ J 2019; 83: 1616
3. 5) Halperin JL, Hankey GJ, Wojdyla DM, et al; ROCKET AF Steering Committee and Investigators: Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation 2014; 130: 138–146
4. 6) Yamada N, Hirayama A, Maeda H, et al: Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism—the J-EINSTEIN DVT and PE program. Thromb J 2015; 13: 2
5. 8) Konstantinides SV, Meyer G, Becattini C, et al: ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41: 543–603